Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma.
Nakamura M, Bax HJ, Scotto D, Souri EA, Sollie S, Harris RJ, Hammar N, Walldius G, Winship A, Ghosh S, Montes A, Spicer JF, Van Hemelrijck M, Josephs DH, Lacy KE, Tsoka S, Karagiannis SN.
Nakamura M, et al. Among authors: van hemelrijck m.
Oncoimmunology. 2019 Mar 28;8(6):e1593811. doi: 10.1080/2162402X.2019.1593811. eCollection 2019.
Oncoimmunology. 2019.
PMID: 31069161
Free PMC article.